Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$14.94
1.128.1%
At close: Sep 18, 5:00 PM EST
$14.94
N/A
After Hours: Sep 18, 5:13 PM EST
Turn Therapeutics Inc (TTRX) Stock Price, Quote, News & History
TTRXNASDAQ
Turn Therapeutics (TTRX) Stock Price, Quote, News & History | Benzinga
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Turn Therapeutics (TTRX) stock?
You can purchase shares of Turn Therapeutics (NASDAQ:TTRX) through any online brokerage.
Who are Turn Therapeutics (TTRX) competitors?
Other companies in Turn Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
What is the forecast, or price target, for Turn Therapeutics (TTRX) stock?
Turn Therapeutics has a consensus price target of $9.00.
What is the current price for Turn Therapeutics (TTRX)?
The stock price for Turn Therapeutics (NASDAQ: TTRX) is $14.94 last updated September 18, 2026 at 5:13 PM EDT.
Does Turn Therapeutics (TTRX) pay a dividend?
There are no upcoming dividends for Turn Therapeutics.
When is Turn Therapeutics (NASDAQ:TTRX) reporting earnings?
Turn Therapeutics does not have any upcoming earnings scheduled.
Is Turn Therapeutics (TTRX) going to split?
There is no upcoming split for Turn Therapeutics.
What sector and industry does Turn Therapeutics (TTRX) operate in?
Turn Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
